Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years old, of any sex
- People who have been diagnosed with stage IV hepatobiliary cancer (cancer of the liver, bile ducts, or gallbladder), confirmed by both imaging scans and tissue testing
- People for whom palliative (comfort-focused) care is the preferred treatment approach
- People whose genetic (NGS) test results show a gene mutation that can be targeted by a medication already approved by the Chinese or US drug regulatory authorities
- People with a relatively good level of physical functioning (able to carry out some daily activities, even if limited — confirm with trial site what this means for a specific case)
- People with a life expectancy of at least 3 months
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People with stage I, II, or III hepatobiliary cancer, or whose cancer may be suitable for surgery aimed at a cure
- People whose genetic (NGS) test shows no relevant gene mutation, or shows a mutation for which no approved targeted medication exists
- People whose physical functioning is significantly limited (confirm with trial site)
- People who are pregnant or not using an effective method of contraception
- People with a history or current presence of serious heart or brain/blood vessel conditions
- People with significant liver or kidney problems, such as jaundice, fluid build-up in the abdomen, or certain abnormal blood or urine test results (confirm with trial site for specific thresholds)
- People with a significant ongoing infection (confirm with trial site for severity level)
- People who have had major surgery within 4 weeks before joining, or who have not yet fully recovered from surgery
- People with epilepsy, or known or untreated cancer that has spread to the brain
- People with wounds, ulcers, or fractures that are not healing, or who have had an organ or tissue transplant in the past
- People with a history of significant bleeding episodes or blood clotting disorders
- People with a known HIV infection
- People with a history of drug misuse or who are unlikely to follow the trial requirements reliably
- People who still have significant side effects from a previous cancer treatment (with some exceptions such as hair loss, anaemia, or thyroid issues — confirm with trial site)
- People who are currently taking part in another clinical trial
- People whom the trial investigator considers unsuitable for the study after careful assessment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wanguang Zhang, Tongji Hospital
Phone: 86-027-83665293
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.